XERS · Forms 3, 4, 5

Insider trades at Xeris Biopharma Holdings, Inc.

3 insiders sold $595K of Xeris Biopharma Holdings, Inc. stock on the open market in the last 30 days.

Every Form 3, 4 and 5 filed for Xeris Biopharma Holdings, Inc. (XERS) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Insider trades in the last 90 days

DateInsiderRoleTransactionSharesPriceValueFiling
Steven PieperSee RemarksSell5,000$9.41$47KForm 4
Kevin McCullochSee RemarksSell15,000$9.41$141KForm 4
Beth HechtSee RemarksSell16,666$9.41$157KForm 4
Kevin McCullochSee RemarksSell25,000$10.00$250KForm 4
Kevin McCullochSee RemarksSell15,000$8.49$127KForm 4
Beth HechtSee RemarksSell16,666$8.49$141KForm 4
Steven PieperSee RemarksSell5,000$8.50$43KForm 4
Steven PieperSee RemarksSell5,000$8.50$43KForm 4
Kevin McCullochSee RemarksSell15,000$8.02$120KForm 4
Beth HechtSee RemarksSell16,666$8.01$134KForm 4
John Patrick Shannon JrSee RemarksTax withholding36,645$8.08$296KForm 4
Kevin McCullochSee RemarksTax withholding21,918$8.08$177KForm 4

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.